Enalapril Maleate/Hydrochlorothiazide

马来酸依那普利/氢氯噻嗪

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEnalapril Maleate/Hydrochlorothiazide
Drug Alias NameHydrochlorothiazide/Enalapril Maleate氢氯噻嗪/马来酸依那普利Enalapril maleate - hydrochlorothiazide mixtVaseretic
ClassificationSmall molecules
Mechanisms of ActionThiazide-sensitive sodium-chloride cotransporter inhibitorsAngiotensin-converting enzyme inhibitors
TargetsThiazide-sensitive sodium-chloride cotransporterAngiotensin-converting enzyme
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryUnited States
Original Approved Date1986/10/31
Country/TerritoryUnited StatesMainland China
CombinationsYes HydrochlorothiazideEnalapril Maleate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesValeant
China Registration ClassN/A

Develop Information

Active CompaniesBausch & Lomb (Singapore) Pvi LtdSinopharm Group Dezhong(Foshan)Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC09BA02
Related LinksKEGG